IL2 and neoplasm: Indeed, similar to NK cells cultured with undifferentiated sensitive tumor stem cells or primary untransformed stem cells, the treatment of NK cells with IL-2 and anti-CD16 mAb resulted in the loss of cytotoxicity, gain in IFN-γ secretion and down modulation of CD16 surface receptors [14], [29].